Incentives for Combining Structure and Process Quality to Improve Outcome in Rheumatic Treatment

Tobias Romeyke, Elisabeth Noehammer and Harald Stummer

SAGE Open, 2022, vol. 12, issue 3, 21582440221126620

Abstract: The study investigates the effects of multidisciplinary treatment for rheumatic treatment regarding (a) financial feasibility based on costs/remuneration in comparison to conventional treatment and (b) Patient reported outcome measures (Proms) to check for effectiveness. For (a), cost data and remuneration with and without multimodal rheumatologic complex treatment (MRCT) is analysed, including cost types. The database encompasses 18,794 treatment cases. For (b), a case study with retrospective patient data analysis ( N  = 375, all treated in a specialized German hospital) regarding self-reported quality of life and physical functions is carried out for subjects receiving MRCT. While conventional treatment is fully covered, MRCT is only incentivized for cases with long in-patient treatment, so financial feasibility for hospitals is limited. Patients with MRCT reported significant improvements in quality of life ( p  

Keywords: rheumatic diseases; patient-related outcomes; multimodal treatment; quality indicators; chronic care (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/21582440221126620 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:sagope:v:12:y:2022:i:3:p:21582440221126620

DOI: 10.1177/21582440221126620

Access Statistics for this article

More articles in SAGE Open
Bibliographic data for series maintained by SAGE Publications ().